Concepedia

Rhoda Arzoomanian

RA

17

Publications

1.1K

Citations

15

H-Index

1991

Active since

Affiliations

University of Wisconsin–Madison(Current)

Spanish Oncology Genitourinary Group

University of Wisconsin Carbone Cancer Center

University of Wisconsin System

Rhoda Arzoomanian is an author at University of Wisconsin–Madison specializing in pharmacology, medicine, and pharmacotherapy.

Top concepts

Publications per year

1991–2004

17

Publications

17

Phase I Pharmacokinetic and Pharmacodynamic Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors

James P. Thomas, Rhoda Arzoomanian, Dona Alberti et al. · Journal of Clinical Oncology · 2003 · 226 citations

A Phase I Trial of Perifosine (NSC 639966) on a Loading Dose/Maintenance Dose Schedule in Patients with Advanced Cancer

Lynn Van Ummersen, Kim Binger, Jennifer Volkman et al. · Clinical Cancer Research · 2004 · 157 citations

Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol

James P. Thomas, Kendra D. Tutsch, James F. Cleary et al. · Cancer Chemotherapy and Pharmacology · 2002 · 122 citations

, , +6

Phase I clinical trial of perillyl alcohol administered daily.

Gregory H. Ripple, Michael N. Gould, James A. Stewart et al. · PubMed · 1998 · 116 citations

, , +18

Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.

Gregory H. Ripple, Michael N. Gould, Rhoda Arzoomanian et al. · PubMed · 2000 · 106 citations

, , +20

Rows per page

1–5 of 17